跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
E7 TCR-T cells
首页
药物
E7 TCR-T cells
E7 TCR-T cells
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS
EP 3149031 A1
申请人: US HEALTH
优先权: 2014
CN
EP
US
WO
14 件公开
MODIFIED CYTOTOXIC T CELLS AND METHODS OF USE THEREOF
EP 4514835 A4
申请人: CUE BIOPHARMA INC
优先权: 2022
EP
US
WO
3 件公开
USE OF ANTIGEN SHORT PEPTIDE IN SCREENING OF DRUG FOR TREATING HPV-RELATED DISEASE, AND TCR SCREENED BY ANTIGEN SHORT PEPTIDE
US 20250325667 A1
申请人: UNIV GUANGZHOU MEDICAL
优先权: 2022
CN
US
3 件公开
HIGH AVIDITY HPV T-CELL RECEPTORS
EP 3156067 A1
申请人: MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN
优先权: 2015
EP
US
2 件公开
T CELLS COMPRISING A CHIMERIC ANTIGEN RECEPTOR TARGETING TRANSFORMING GROWTH FACTOR BETA AND A T CELL RECEPTOR TARGETING A TUMOR ANTIGEN, AND USE THEREOF
WO 2025096419 A1
申请人: LYELL IMMUNOPHARMA INC
优先权: 2023
WO
TCR (T cell receptor) for recognizing E711-19 epitope peptide or antigen binding fragment thereof and application of TCR or antigen binding fragment
CN 122187947 A
申请人: UNIV CHONGQING MEDICAL
优先权: 2024
CN
TCR for recognizing HPV16 antigen and application thereof
CN 120118175 A
申请人: XINJING ZHIYUAN BIOLOGICAL TECH SUZHOU CO LTD
优先权: 2025
CN
药物
反馈